Conexiant
Login
  • The Analytical Scientist
  • The Cannabis Scientist
  • The Medicine Maker
  • The Ophthalmologist
  • The Pathologist
  • The Traditional Scientist
The Pathologist
  • Explore Pathology

    Explore

    • Latest
    • Insights
    • Case Studies
    • Opinion & Personal Narratives
    • Research & Innovations
    • Product Profiles

    Featured Topics

    • Molecular Pathology
    • Infectious Disease
    • Digital Pathology

    Issues

    • Latest Issue
    • Archive
  • Subspecialties
    • Oncology
    • Histology
    • Cytology
    • Hematology
    • Endocrinology
    • Neurology
    • Microbiology & Immunology
    • Forensics
    • Pathologists' Assistants
  • Training & Education

    Career Development

    • Professional Development
    • Career Pathways
    • Workforce Trends

    Educational Resources

    • Guidelines & Recommendations
    • App Notes

    Events

    • Webinars
    • Live Events
  • Events
    • Live Events
    • Webinars
  • Profiles & Community

    People & Profiles

    • Power List
    • Voices in the Community
    • Authors & Contributors
  • Multimedia
    • Video
    • Podcasts
Subscribe
Subscribe

False

The Pathologist / Issues / 2021 / Dec / Defining the Next Generation of NGS
Digital and computational pathology Genetics and epigenetics Technology and innovation Research and Innovations

Defining the Next Generation of NGS

Overcoming challenges of the typical NGS workflow with the Ion Torrent™ Genexus™ System

12/31/2021 1 min read

Sponsored By

Share

Next-generation sequencing (NGS) is becoming an increasingly significant part of genomics testing, but the technological footprint and expertise involved make it difficult to implement in many labs. Thus, the sheer power of NGS becomes its weakness – it can interrogate thousands of genes at a time, but the time, resources, and knowledge required all make the technique the province of specialized labs that accept outsourced work. Ordinary labs, for whom the size and complexity of NGS equipment means it may not even physically fit in their space-constrained laboratories, have had few other options but to accept the difficulties and delays of this workflow. However, thanks to the Ion Torrent™ Genexus™ System, the days of outsourcing NGS research are numbered.

Consisting of two connected devices – the Ion Torrent Genexus Purification System and the Genexus Integrated Sequencer – the Genexus system provides an almost completely automated workflow with as little as 20 minutes of hands-on time and results ready for analysis within one day – a far cry from the multi-day process of many other NGS workflows. This level of automation helps increase reproducibility and efficiency and reduce personnel costs. The Genexus system also avoids the challenges of cobbling together a working solution from different manufacturers; the software follows samples from beginning to end, making error detection and method control simple and intuitive.

For applications as diverse as oncology biomarker profiling, SARS-CoV-2 research assays, and inherited disease research, the Genexus system offers an easy solution. Up to four distinct assays can be combined into a single run (even with as little as one sample in the run), enabling the Genexus system to scale up or down as needed. Its GX5 gene chip can even be partially used and then finished at a later time with other samples due to its high stability.

Thermo Fisher Scientific provides ample and easily accessible support for the Genexus System, including hands-on orientation with its SmartStart program, training centers around the world, smart remote support, and field service engineers available on short notice to diagnose and repair problems. The company’s consulting and qualification services also improve the chances for performing installation and qualification testing – ensuring that instruments are functioning correctly and ready to go. Similarly, Thermo’s analytical validation services can accelerate the researcher’s launch timetable and reduce costs by providing project management services and managing the analytical validation workflow – helping researchers to make sure their assays perform at the expected level and instruments operate within desired parameters. With all this in mind, it’s clear that the Genexus System supports molecular labs in working to their fullest potential.

Learn more at: www.oncomine.com/genexus.

Newsletters

Receive the latest pathology news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

Explore More in Pathology

Dive deeper into the world of pathology. Explore the latest articles, case studies, expert insights, and groundbreaking research.

False

Advertisement

Recommended

False

Related Content

Global Referral
Digital and computational pathology
Global Referral

January 12, 2024

10 min read

How digital pathology is transforming the delivery of remote second opinions

Cracking Colon Cancer
Digital and computational pathology
Cracking Colon Cancer

January 25, 2024

1 min read

How a new clinically approved AI-based tool enables rapid microsatellite instability detection

The (Pathology) IT Crowd?
Digital and computational pathology
The (Pathology) IT Crowd?

December 30, 2021

5 min read

The pathologist’s guide to IT considerations for digitization

Defining the Next Generation of NGS
Digital and computational pathology
Defining the Next Generation of NGS

December 31, 2021

1 min read

Overcoming challenges of the typical NGS workflow with the Ion Torrent™ Genexus™ System

False

The Pathologist
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2025 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.